Actinium Pharmaceuticals, Inc. (ATNM)
AMEX·Healthcare·Biotechnology
$1.44
+2.50%
Mkt Cap $37.44M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$11.07
Range $4.00 – $24.26
Implied Upside
+671.4%
Consensus $11.07 vs current $1.44
AMEX·Healthcare·Biotechnology
$1.44
+2.50%
Mkt Cap $37.44M
No recent rating data.
Price Target (3 analysts)
$11.07
Range $4.00 – $24.26
+671.4%
Consensus $11.07 vs current $1.44